LexDanaLexDanabeta
Inventor

Murray D. Bailey

Inventor
Pierrefonds, CA

Overview

35→
Patents
1998–2016
Patent span
Chemistry
Primary field (CPC C)

Patents· 35 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes22%
C07DHeterocyclic compounds20%
C07KPeptides19%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture9%
Y02ATechnologies for adaptation to climate change4%
C12NMicroorganisms or enzymes2%
C07CAcyclic or carbocyclic compounds1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
9,315,499'Cytomegalovirus inhibitor compounds'20169,249,158'Cytomegalovirus inhibitor compounds'20168,841,331'Inhibitors of human immunodeficiency virus replication'20148,710,230'Inhibitors of human immunodeficiency virus replication'20148,461,180'Inhibitors of human immunodeficiency virus replication'20138,377,960'Inhibitors of human immunodeficiency virus replication'20138,354,429'Inhibitors of human immunodeficiency virus replication'20138,338,441'Inhibitors of human immunodeficiency virus replication'20128,067,438'Hepatitis C inhibitor compounds'20117,939,667'Hepatitis C inhibitor compounds'2011RE042164'Hepatitis C inhibitor tri-peptides'2011RE041894'Hepatitis C inhibitor tri-peptides'20107,767,818'Hepatitis C inhibitor dipeptide analogs'20107,749,961'Macrocyclic peptides active against the hepatitis C virus'2010RE041356'Hepatitis C inhibitor tri-peptides'20107,705,146'Hepatitis C inhibitor peptide analogs'20107,696,242'Hepatitis C inhibitor peptide analogs'20107,642,235'Macrocyclic peptides active against the hepatitis C virus'20107,585,845'Hepatitis C inhibitor compounds'20097,511,157'Hepatitis C inhibitor dipeptide analogs'20097,504,378'Macrocyclic peptides active against the hepatitis C virus'2009RE040525'Hepatitis C inhibitor tri-peptides'20087,091,184'Hepatitis C inhibitor tri-peptides'20066,908,901'Hepatitis C inhibitor peptide analogs'20056,767,991'Hepatitis C inhibitor peptides'20046,534,523'Hepatitis C inhibitor tri-peptides'20036,420,380'Hepatitis C inhibitor tri-peptides'20026,410,531'Hepatitis C inhibitor tri-peptides'20026,329,417'Hepatitis C inhibitor tri-pepitides'20016,329,379'Hepatitis C inhibitor tri-peptides'20016,323,180'Hepatitis C inhibitor tri-peptides'20016,291,640'Peptidomimetic inhibitors of the human cytomegalovirus protease'20016,268,207'Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester'20016,143,715'Hepatitis C inhibitor peptide analogues'20005,808,085'Stereoselective preparation of 2-substituted succinic acid derivatives'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2011Patents assigned to BOEHRINGER INGELHEIM CA LTD (14)· patent assignee history
1998–2016Based in Pierrefonds, CA· patent location history
2005–2016Patents assigned to BOEHRINGER INGELHEIM INT (14)· patent assignee history
2006–2014Based in Laval, CA· patent location history
2012–2016Patents assigned to FADER LEE (6)· patent assignee history
2012–2014Patents assigned to GILEAD SCIENCES INC (6)· patent assignee history
2012–2016Patents assigned to BILODEAU FRANCOIS (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOEHRINGER INGELHEIM CA LTD141998–2011
BOEHRINGER INGELHEIM INT142005–2016
FADER LEE62012–2016
GILEAD SCIENCES INC62012–2014
BILODEAU FRANCOIS52012–2016
Locations
LocationPatentsSpan
Pierrefonds, CA271998–2016
Laval, CA82006–2014